Replies to post #3747 on Repros Therapeutics, Inc. (RPRX)

[docbanker]

y, its either partnership of some sort or small financing once more data is in (efficacy data like chronic fibroids, interim endo and potentially Hgb). If this is truly a concern, you should look at the action in the stock the last 2 times he raised $ (2004 and feb 2007)- stock traded up during roadshow and was priced well above where roadshow started.